RecruitingNCT03125655

Regulation of Inflammatory Genes in Psoriasis

Sponsor

University of Alabama at Birmingham

Enrollment

13 participants

Start Date

Apr 22, 2014

Study Type

OBSERVATIONAL

Conditions

Psoriasis Inflammation

Summary

Psoriasis is a chronic and recurrent skin disorder characterized by marked inflammatory changes in the skin. An extensive cytokine network including generated by activated dendritic cells and T cells mediates the formation of psoriatic lesions. These immune-response parameters can be used as markers in the severity and management of the disease after further in-depth studies.

Eligibility

Min Age: 19 YearsMax Age: 99 Years

Inclusion Criteria3

Clinical diagnosis of psoriasis
Must be age 19 or older.
Must be Fitzpatrick skin type I, II, III, IV, V, VI.

Exclusion Criteria4

Subjects who do not have photosensitive disease and are not on photosensitizing medications.
Subjects with a history of keloids (who are more likely to develop hypertrophic scars following skin biopsy).
Subjects who have an allergy to local anesthetics, antibiotics and/or anticoagulants.
Subjects who are pregnant.

Interested in this trial?

Get notified about updates and connect with the research team.